0001805698-26-000001.txt : 20261006 0001805698-26-000001.hdr.sgml : 20261006 20261005180517 ACCESSION NUMBER: 0001805698-26-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261006 DATE AS OF CHANGE: 20261005 EFFECTIVENESS DATE: 20261006 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EIKONOKLASTES THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001805698 ORGANIZATION NAME: EIN: 843230045 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-552987 FILM NUMBER: 261441796 BUSINESS ADDRESS: STREET 1: 2356 PARK AVENUE STREET 2: UNIT 17 CITY: CINCINNATI STATE: OH ZIP: 45206 BUSINESS PHONE: (513) 549-6484 MAIL ADDRESS: STREET 1: 2356 PARK AVENUE STREET 2: UNIT 17 CITY: CINCINNATI STATE: OH ZIP: 45206 D/A 1 primary_doc.xml X0708 D/A LIVE 0001805698 EIKONOKLASTES THERAPEUTICS, INC. 2356 PARK AVENUE UNIT 17 CINCINNATI OH OHIO 45206 (513) 549-6484 DELAWARE None None Corporation true Bruce Halpryn 2356 Park Avenue Unit 17 Cincinnati OH OHIO 45206 Executive Officer Director Samuel Lee 2356 Park Avenue Unit 17 Cincinnati OH OHIO 45206 Executive Officer Director Kenneth Morand 2356 Park Avenue Unit 17 Cincinnati OH OHIO 45206 Director Thomas Finn 2356 Park Avenue Unit 17 Cincinnati OH OHIO 45206 Director Robert Johnson 2356 Park Avenue Unit 17 Cincinnati OH OHIO 45206 Director Joseph Nolan 2356 Park Avenue Unit 17 Cincinnati OH OHIO 45206 Director Pharmaceuticals Decline to Disclose 06b true 0001805698-25-000002 2025-07-14 false true false 0 18638880 16055106 2583774 false 15 0 0 0 false EIKONOKLASTES THERAPEUTICS, INC. Bruce Halpryn Bruce Halpryn Chief Executive Officer 2026-10-05